Clinical Trial Update: Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment [NA]

View source ↗

Summary

A completed clinical trial (NCT05411822) evaluating circadian responses to light in people with mild cognitive impairment and Alzheimer disease, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Mild Cognitive Impairment, Alzheimer Disease | NA | Status: COMPLETED | Results posted: 2025-06-24